CAN GUT MICROBIOTA INFLUENCE THE ACTION OF LEVODOPA DRUGS, LEVEL OF HOMOCYSTEINE AND FREQUENCY OF DEFECATION?
This review focuses on how the normalization of intestinal microflora can lead to an improvement in the action of levodopa, reduce levels of homocysteine and increase the frequency of bowel movements of patients with Parkinson''s disease in the later stages. Research methods are proposed.